T1DAL Study enrolls first participant!
The clinical/translational type 1 diabetes trial (T1DAL) headed up by Dr. Mark RIgby recently opened and enrolled their first participant nationwide at Emory last week. (March 31. 2011)
For more information about this trial, please go to: www.t1dal.org